Free Trial

BioCryst Pharmaceuticals (BCRX) SEC Filings & 10K Form

BioCryst Pharmaceuticals logo
$8.54 -0.07 (-0.81%)
Closing price 04:00 PM Eastern
Extended Trading
$8.53 -0.01 (-0.12%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BioCryst Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/24/2025
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:09 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:13 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
6:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:19 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:11 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:05 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:22 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:10 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:03 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:06 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:35 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:23 PM
BioCryst Pharmaceuticals (Subject)
Hutson Nancy J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:06 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
9:52 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
9:25 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/05/2024
4:19 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:52 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/02/2024
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
6:11 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
11:09 AM
BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
08/05/2024
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:39 PM
BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:31 PM
BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:27 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:28 PM
BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:31 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:33 PM
BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:18 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:33 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
6:21 AM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
6:24 AM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:08 AM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:11 AM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk Wants to Audit Fort Knox—What It Means for Your Retirement (Ad)

You can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FREE. All you need is to know these 2 "magic words" only revealed inside your FREE copy of this 2025 Gold Guide.

Tap the link to get your free 2025 Gold Guide now
05/15/2024
6:14 AM
BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:17 AM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:19 AM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:04 AM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
6:03 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:26 PM
BioCryst Pharmaceuticals (Filer)
Form ARS
04/02/2024
3:21 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:32 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCRX) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners